Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 14, 2016 5:01 PM ET

Pharmaceuticals

Company Overview of Luitpold Pharmaceuticals, Inc.

Company Overview

Luitpold Pharmaceuticals, Inc. engages in the development, manufacture, and distribution of pharmaceutical products and medical devices for various medical, dental, and veterinary needs. It offers injectable parenteral medications, such as therapeutic injectables, electrolytes and IV additives, multiple trace element and electrolyte additives, single entity trace elements, inhalation and oral solutions, ophthalmics and otics, latex free products, and preservative free products for use in pharmacy admixtures and nutrient solutions, critical care drugs, antidotes, diluents, and medicinal dyes. The company also provides custom-manufactured injectable products for pharmaceutical and biotechnolog...

One Luitpold Drive

P.O. Box 9001

Shirley, NY 11967

United States

Founded in 1947

Phone:

631-924-4000

Fax:

631-924-1731

Key Executives for Luitpold Pharmaceuticals, Inc.

Chief Executive Officer and President
Vice President
Age: 64
Compensation as of Fiscal Year 2015.

Luitpold Pharmaceuticals, Inc. Key Developments

Luitpold Pharmaceuticals, Inc. Reports Revenue Results for the First Quarter of Fiscal 2016; Revised Revenue Guidance for Fiscal 2016

Luitpold Pharmaceuticals, Inc. reported revenue results for the first quarter of fiscal 2016. Revenue was JPY 21.5 billion against JPY 12.5 billion last year. The company revised revenue guidance for fiscal 2016. The company expects revenue of JPY 76.0 billion against previous guidance of JPY 72.0 billion.

Similar Private Companies By Industry

Company Name Region
RXNB Inc. United States
Ayurcore, Inc. United States
Sentinella Pharmaceuticals, Inc. United States
P3 Laboratories, LLC United States
Lung Biotechnology PBC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Luitpold Pharmaceuticals, Inc., please visit www.luitpold.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.